多中心经验:血管内碎石术用于高危患者经颈动脉血运重建术中严重钙化的治疗
本研究在九家机构连续纳入2018至2022年接受经颈动脉血运重建联合血管内碎石术(TCAR+IVL)的58例患者,评估其安全性和有效性。技术成功率为100%,98%的患者残余狭窄小于30%;30天内同侧新发卒中率为1.7%,任何新发同侧神经系统事件(卒中/短暂性脑缺血发作)率为6.8%。作者认为这些结果引发了对TCAR+IVL风险的担忧,以及该策略是否适用于可能接受颈动脉内膜切除术的患者。
要点
- 58例高危患者接受TCAR+IVL,技术成功率达100%,98%残余狭窄小于30%。
- 30天内同侧新发卒中1例(1.7%),任何新发同侧神经系统事件4例(6.8%)。
- 作者认为结果引发对TCAR+IVL风险的担忧及其对可能接受CEA患者的适用性。
核心结论
- IVL可充分重塑钙化颈动脉以有效辅助TCAR,适用于传统上禁忌的钙化病变患者。
- 1例患者(1.7%)在30天内发生卒中,但4例患者(6.8%)出现任何新发神经系统事件(卒中/短暂性脑缺血发作)。
- 这些结果引发了对TCAR+IVL风险的担忧,以及该策略是否适用于可能接受颈动脉内膜切除术的患者。
研究设计与样本
- 多中心研究,纳入2018至2022年在九家机构连续接受TCAR+IVL的患者。
- 共58例患者,62%为男性,平均年龄78±6.6岁;22例(38%)为症状性疾病。
- 57例(98%)符合颈动脉内膜切除术的高危解剖或生理标准。
- IVL联合预扩张血管成形术,在支架置入前治疗钙化血管。
主要发现
- 47例患者有严重钙化病变;14例(30%)为孤立偏心斑块,20例(43%)为孤立环周斑块,13例(27%)为偏心及环周钙化。
- 平均手术时间和血流逆转时间分别为87±27分钟和25±14分钟;每例碎石脉冲中位数为90次(范围30-330),平均造影剂用量为29 mL。
- 术中无患者出现脑电图改变或新发神经功能缺损;技术成功率为100%,98%的患者完成造影时残余狭窄小于30%。
- 1例患者(1.72%)发生院内术后卒中;30天内共4例患者出现任何新发同侧神经系统事件(卒中/短暂性脑缺血发作),总体发生率为6.8%;其中1例短暂性脑缺血发作和1例卒中发生在指数住院期间,2例短暂性脑缺血发作发生在出院后。
- 发生任何术后神经系统事件的患者术前平均狭窄为93%,未发生卒中/短暂性脑缺血发作的患者为86%(P=0.32);发生新发神经系统事件的患者慢性肾功能不全比例更高(75% vs 17%;P=0.005);两组在钙化、手术或患者特征方面无差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Transcarotid artery revascularization (TCAR) offers a safe alternative to carotid endarterectomy (CEA), but severe calcification is currently considered a contraindication in carotid artery stenting. This study aims to describe the safety and effectiveness of TCAR with intravascular lithotripsy (IVL) in patients with traditionally prohibitive calcific disease. METHODS: All consecutive patients who underwent TCAR+IVL from 2018-2022 at nine institutions were identified. IVL was combined with pre-dilatation angioplasty to treat calcified vessels before stent deployment. The primary outcome was a new ipsilateral stroke within 30 days. Secondary outcomes included any new ipsilateral neurologic event (stroke/transient ischemic attack [TIA]) at 30 days, technical success, and <30% residual stenosis. RESULTS: Fifty-eight patients (62% male; mean age, 78 ± 6.6 years) underwent TCAR+IVL, with 22 (38%) for symptomatic disease. Fifty-seven patients (98%) met high-risk anatomical or physiologic criteria for CEA. Forty-seven patients had severely calcific lesions. Fourteen patients (30%) had isolated eccentric plaque, 20 patients (43%) had isolated circumferential plaque, and 13 (27%) had eccentric and circumferential calcification. Mean procedure and flow reversal times were 87 ± 27 minutes and 25 ± 14 minutes. The median number of lithotripsy pulses per case was 90 (range, 30-330), and mean contrast usage was 29 mL. No patients had electroencephalogram changes or new deficits observed intraoperatively. Technical success was achieved in 100% of cases, with 98% having <30% residual stenosis on completion angiography. One patient had an in-hospital post-procedural stroke (1.72%). Four patients total had any new ipsilateral neurologic event (stroke/TIA) within 30 days for an overall rate of 6.8%. One TIA and one stroke occurred during the index hospitalization, and two TIAs occurred after discharge. Preoperative mean stenosis in patients with any postoperative neurologic event was 93% (vs 86% in non-stroke/TIA patients; P = .32), and chronic renal insufficiency was higher in patients who had a new neurologic event (75% vs 17%; P = .005). No differences were observed in calcium, procedural, or patient characteristics between the two groups. The mean follow-up was 132 days (range, 19-520 days). Three stents developed recurrent stenosis (5%) on follow-up duplex; the remainder were patent without issue. There were no reported interventions for recurrent stenosis during the study period. CONCLUSIONS: IVL sufficiently remodels calcified carotid arteries to facilitate TCAR effectively in patients with traditionally prohibitive calcific disease. One patient (1.7%) suffered a stroke within 30 days, although four patients (6.8%) sustained any new neurological event (stroke/TIA). These results raise concerns about the risks of TCAR+IVL and whether it is an appropriate strategy for patients who could potentially undergo CEA.
引用
- DiLosa K, Schonefeld S, El-Khoury R, et al. Multi-center experience with intravascular lithotripsy for treatment of severe calcification during transcarotid artery revascularization for high-risk patients. J Vasc Surg. 2024. PMID: 38777157. doi:10.1016/j.jvs.2024.04.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。